• Nachrichtendetail
• 

26.04.2024 14:21:38 - dpa-AFX: *CHMP BACKS J&J'S RYBREVANT COMBO FOR FIRST-LINE NSCLC WITH EGFR EXON 20 MUTATION

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	JOHNSON + JOHNSON DL 1	853260	Xetra	140,160	16.05.24 10:53:45	+0,700	+0,50%	140,060	140,280	139,980	139,460